Divarasib plus cetuximab is well tolerated in patients with KRAS G12C-positive colorectal cancer.
Cancer Res (2023) 83 (8_Supplement): LB215.
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Department of Medicine, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, ...
Abstract. Macrophages are a type of immune cell that play a crucial role in the tumor microenvironment. In tumors, macrophages can be polarized towards a pro-inflammatory phenotype, referred to as M1, ...
1AstraZeneca, ICC, Early Oncology, R&D, Cambridge, United Kingdom.
1Department of Oncology, University of Lausanne, Lausanne, Switzerland.
Cancer Res (2024) 84 (17_Supplement): A006.
1Adult Stem Cell Research Center and Research Institute for Veterinary Science, Seoul, Republic of Korea.
1Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio. 2Division of Cancer Prevention and Control, Department of Internal Medicine, College of Medicine, The Ohio State University, ...
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio (avelumab), a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback